TNFRSF17 and plasma cell myeloma: For example, PI3K inhibition in conjunction with BCMA-directed CAR-T cells in Burkitt lymphoma- and multiple myeloma-bearing mice resulted in long-term tumor regression, with an increased frequency of CD8 + CD62L + memory T cells [25].